Skip to main content
Sadhana Nitrochem Ltd. logo

Sadhana Nitrochem Ltd. — Investor Relations & Filings

Ticker · SADHNANIQ ISIN · INE888C01040 BSE.NS Manufacturing
Open in API
Filings indexed 837 across all filing types
Latest filing 2024-05-10 Regulatory Filings
Country IN India
Listing BSE.NS SADHNANIQ

About Sadhana Nitrochem Ltd.

https://www.sncl.com

Sadhana Nitrochem Ltd. specializes in the manufacture of chemical intermediates and performance chemicals. The company's core product portfolio includes nitrobenzene and its downstream derivatives such as metanilic acid, aniline 2,5 disulphonic acid, and sodium meta nitrobenzene sulphonate. These products serve as critical raw materials for the global dyes, pigments, pharmaceuticals, and agrochemicals sectors. The company operates advanced manufacturing facilities focused on high-purity chemical synthesis and process optimization. Its technical capabilities extend to specialized chemical reactions including nitration, hydrogenation, and sulfonation. By maintaining a vertically integrated production model, the company ensures consistent quality and supply chain reliability for its international client base across various industrial applications.

Recent filings

Filing Released Lang Actions
Board Meeting — SADHANA NITROCHEM LIMITED has informed the Exchange about Board Meeting to be held on 17-May-2024 to consider and approve the Yearly Audited Financial results of the Company for the p…
Regulatory Filings
2024-05-10 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for May 17, 2024. It mentions the agenda items including consideration of audited financial results for the quarter and financial year ended March 31, 2024, and dividend recommendation. The document is brief (2022 characters) and serves as an intimation or announcement rather than containing the actual financial results or detailed report. It also references compliance with SEBI regulations and insider trading rules. Since it is an announcement of a Board Meeting and not the actual financial report or results, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories. It is not a full Annual Report, Earnings Release, or Management Report, nor is it a report publication announcement because it does not mention the report being attached or published. Therefore, the classification is RNS with high confidence.
2024-05-10 English
SADHANA NITROCHEM LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/05/2024 ,inter alia, to consider and approve Pursuant to Regulation 29 ....
Regulatory Filings Classification · 95% confidence The document is a short notice informing stock exchanges about an upcoming Board Meeting scheduled for May 17, 2024. It mentions the agenda items including consideration of audited financial results for the quarter and financial year ended March 31, 2024, and dividend recommendation. The document is an intimation or announcement of a future event (Board Meeting) rather than the actual financial results or reports. It is also under 5,000 characters and serves as a regulatory announcement to exchanges. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and not as the actual financial report or earnings release.
2024-05-10 English
Pursuant to Regulation 7(3) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, please find attached herewith the Compliance Certificate of Sadhana Nitro Chem Limited ....
Regulatory Filings Classification · 95% confidence The document is a compliance certificate addressed to stock exchanges regarding the maintenance of physical and electronic share transfer facilities by the company's Registrar and Share Transfer Agent. It references Regulation 7(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and certifies compliance for the year ended March 31, 2024. The document is a certification letter rather than a financial report or announcement of financial results. It does not contain financial statements or substantive financial data. It is primarily a regulatory compliance filing and certification. Therefore, it fits best under Regulatory Filings (RNS). The document length is 3590 characters, which is relatively short and consistent with a certification letter rather than a full report.
2024-04-19 English
In accordance with Regualtion 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2024, based on the certificate received from Link In-time ....
Regulatory Filings Classification · 95% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended March 31, 2024. It includes a confirmation letter from the registrar and transfer agent (Link Intime India Pvt. Ltd.) and detailed tabular data on demat/remat requests received and released during the quarter. The document is a compliance certificate and confirmation report related to securities dematerialization, not a financial report, earnings release, or management discussion. It is not an announcement of a report but a regulatory compliance certificate with supporting data. This fits best under Regulatory Filings (RNS), which covers compliance documents and officer certifications that do not constitute full financial or management reports.
2024-04-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 100% confidence The document is a certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialization of securities for the quarter ended March 31, 2024. It includes a certificate from the Registrar and Transfer Agent (RTA) Link Intime India Pvt. Ltd. and detailed tabular data on demat/remat requests received and released during the quarter. The document is a compliance certificate and confirmation letter rather than a financial report or announcement of financial results. It does not contain financial statements, earnings data, or management discussion. It is primarily a regulatory compliance filing confirming securities dematerialization and listing status. Therefore, it fits best under Regulatory Filings (RNS) as it is a regulatory compliance certificate and report, not a financial report or announcement.
2024-04-18 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.